Sustained translational repression by eIF2α-P mediates prion neurodegeneration.

PubWeight™: 3.54‹?› | Rank: Top 1%

🔗 View Article (PMC 3378208)

Published in Nature on May 06, 2012

Authors

Julie A Moreno1, Helois Radford, Diego Peretti, Joern R Steinert, Nicholas Verity, Maria Guerra Martin, Mark Halliday, Jason Morgan, David Dinsdale, Catherine A Ortori, David A Barrett, Pavel Tsaytler, Anne Bertolotti, Anne E Willis, Martin Bushell, Giovanna R Mallucci

Author Affiliations

1: MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9HN, UK.

Articles citing this

(truncated to the top 100)

Targeting the unfolded protein response in disease. Nat Rev Drug Discov (2013) 3.37

Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell (2014) 2.63

RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration. Nature (2015) 2.41

Altered ribostasis: RNA-protein granules in degenerative disorders. Cell (2013) 2.38

Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat Neurosci (2013) 2.35

Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener (2012) 1.95

Remote control of gene function by local translation. Cell (2014) 1.72

Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet (2013) 1.63

Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. Elife (2015) 1.61

Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia. JAMA Neurol (2014) 1.51

Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways. PLoS Pathog (2015) 1.49

Protein synthesis rate is the predominant regulator of protein expression during differentiation. Mol Syst Biol (2013) 1.46

PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease. PLoS One (2013) 1.45

Translation of 5' leaders is pervasive in genes resistant to eIF2 repression. Elife (2015) 1.40

Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor. J Neurosci (2015) 1.38

Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature (2016) 1.37

Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice. J Exp Med (2013) 1.13

Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review. Gerontology (2013) 1.11

Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion (2012) 1.11

Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog (2012) 1.10

Multiple Mechanisms of Unfolded Protein Response-Induced Cell Death. Am J Pathol (2015) 1.08

The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol (2015) 1.05

The unfolded protein response is shaped by the NMD pathway. EMBO Rep (2015) 1.05

Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol (2013) 1.04

Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis (2015) 1.02

PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Neurobiol Aging (2014) 1.00

Selective vulnerability to neurodegenerative disease: the curious case of Prion Protein. Dis Model Mech (2014) 0.98

An enhanced integrated stress response ameliorates mutant SOD1-induced ALS. Hum Mol Genet (2013) 0.98

PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol (2015) 0.97

Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int J Cell Biol (2013) 0.97

The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol Commun (2013) 0.95

Pathological stress granules in Alzheimer's disease. Brain Res (2014) 0.94

ALS-linked protein disulfide isomerase variants cause motor dysfunction. EMBO J (2016) 0.94

Alternative fates of newly formed PrPSc upon prion conversion on the plasma membrane. J Cell Sci (2013) 0.93

Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response. Immunology (2013) 0.93

Prion disease tempo determined by host-dependent substrate reduction. J Clin Invest (2014) 0.92

Novel VCP modulators mitigate major pathologies of rd10, a mouse model of retinitis pigmentosa. Sci Rep (2014) 0.92

Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry (2015) 0.91

The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress. Cell Death Dis (2014) 0.90

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa. Cell Death Dis (2014) 0.89

The elusive role of the prion protein and the mechanism of toxicity in prion disease. PLoS Pathog (2015) 0.89

The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein. J Biol Chem (2015) 0.89

Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy (2016) 0.88

Review: Modulating the unfolded protein response to prevent neurodegeneration and enhance memory. Neuropathol Appl Neurobiol (2015) 0.88

Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key? Exp Neurobiol (2014) 0.88

Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson's disease. Cell Death Dis (2016) 0.87

Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat Commun (2015) 0.87

Prions: generation and spread versus neurotoxicity. J Biol Chem (2014) 0.86

De novo prion aggregates trigger autophagy in skeletal muscle. J Virol (2013) 0.86

Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury. Compr Physiol (2015) 0.86

Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules. J Neurosci (2016) 0.86

ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. PLoS One (2014) 0.85

Synaptic dysfunction in prion diseases: a trafficking problem? Int J Cell Biol (2013) 0.85

Therapies for human prion diseases. Am J Neurodegener Dis (2013) 0.85

Early increase and late decrease of purkinje cell dendritic spine density in prion-infected organotypic mouse cerebellar cultures. PLoS One (2013) 0.84

Activation of mTOR: a culprit of Alzheimer's disease? Neuropsychiatr Dis Treat (2015) 0.83

Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum Mol Genet (2016) 0.83

Drosophila as an In Vivo Model for Human Neurodegenerative Disease. Genetics (2015) 0.83

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease. Front Aging Neurosci (2015) 0.82

Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor. Proc Natl Acad Sci U S A (2014) 0.82

Manganese disturbs metal and protein homeostasis in Caenorhabditis elegans. Metallomics (2014) 0.82

Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment. Brain (2015) 0.82

Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains. J Pharmacol Exp Ther (2015) 0.82

Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. Int J Cell Biol (2013) 0.82

The unfolded protein response: mechanisms and therapy of neurodegeneration. Brain (2016) 0.82

Snord 3A: a molecular marker and modulator of prion disease progression. PLoS One (2013) 0.81

Neurodegeneration and unfolded-protein response in mice expressing a membrane-tethered flexible tail of PrP. PLoS One (2015) 0.81

Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling. EMBO J (2016) 0.81

Early Delivery of Misfolded PrP from ER to Lysosomes by Autophagy. Int J Cell Biol (2013) 0.81

Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice. Immunology (2015) 0.81

Prion replication elicits cytopathic changes in differentiated neurosphere cultures. J Virol (2013) 0.81

Tumor progression and the different faces of the PERK kinase. Oncogene (2015) 0.80

Smoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons. J Neurosci (2016) 0.79

Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo. Mol Neurodegener (2016) 0.79

KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun (2015) 0.79

CHIP, a carboxy terminus HSP-70 interacting protein, prevents cell death induced by endoplasmic reticulum stress in the central nervous system. Front Cell Neurosci (2015) 0.79

Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis. J Neurosci (2016) 0.79

Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations. Brain Res (2016) 0.79

Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain. J Alzheimers Dis (2015) 0.78

Targeting synaptic pathology with a novel affinity mass spectrometry approach. Mol Cell Proteomics (2014) 0.78

Guanabenz (Wytensin™) selectively enhances uptake and efficacy of hydrophobically modified siRNAs. Nucleic Acids Res (2015) 0.78

Prion degradation pathways: Potential for therapeutic intervention. Mol Cell Neurosci (2015) 0.78

Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis. J Proteome Res (2014) 0.77

Familial prion protein mutants inhibit Hrd1-mediated retrotranslocation of misfolded proteins by depleting misfolded protein sensor BiP. Hum Mol Genet (2016) 0.77

Persistent prion infection disturbs the function of Oct-1, resulting in the down-regulation of murine interferon regulatory factor-3. Sci Rep (2014) 0.77

Cytosolic PrP can participate in prion-mediated toxicity. J Virol (2014) 0.77

Dysregulated axonal RNA translation in amyotrophic lateral sclerosis. Wiley Interdiscip Rev RNA (2016) 0.77

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau. Elife (2016) 0.77

The importance of prions. PLoS Pathog (2013) 0.77

Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system. Acta Neuropathol (2015) 0.77

Guanabenz Repurposed as an Antiparasitic with Activity against Acute and Latent Toxoplasmosis. Antimicrob Agents Chemother (2015) 0.77

Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters. Neurotherapeutics (2017) 0.77

Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy. ASN Neuro (2016) 0.77

Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex. J Biol Chem (2016) 0.77

Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease. Front Cell Dev Biol (2017) 0.77

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. Brain (2017) 0.76

Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation. PLoS Pathog (2015) 0.76

Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes. Exp Mol Med (2017) 0.76

Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Neurobiol Aging (2016) 0.76

TRNA mutations that affect decoding fidelity deregulate development and the proteostasis network in zebrafish. RNA Biol (2014) 0.76

Articles cited by this

Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06

Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell (2000) 17.44

Adapting proteostasis for disease intervention. Science (2008) 13.22

Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46

Molecular biology of prion diseases. Science (1991) 10.83

A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science (2005) 7.98

Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science (2003) 4.57

A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci (2009) 3.89

Translational regulation of gene expression during conditions of cell stress. Mol Cell (2010) 3.38

Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29

Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA (1998) 3.00

Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature (2011) 2.74

Flavonol activation defines an unanticipated ligand-binding site in the kinase-RNase domain of IRE1. Mol Cell (2010) 2.74

Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron (2007) 2.58

Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J (2003) 2.34

Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J (2002) 2.26

PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration (1994) 2.21

Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07

Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J Neurosci (2007) 2.06

The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol (2005) 2.05

Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01

Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun (2007) 1.98

The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol (2009) 1.92

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71

Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J Neuropathol Exp Neurol (2006) 1.49

Eif-2a protects brainstem motoneurons in a murine model of sleep apnea. J Neurosci (2008) 1.28

Overexpressed protein disulfide isomerase in brains of patients with sporadic Creutzfeldt-Jakob disease. Neurosci Lett (2002) 1.27

High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther (2004) 1.23

Abeta 1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner. Antioxid Redox Signal (2007) 1.23

Nitric oxide is an activity-dependent regulator of target neuron intrinsic excitability. Neuron (2011) 1.16

Diminishing apoptosis by deletion of Bax or overexpression of Bcl-2 does not protect against infectious prion toxicity in vivo. J Neurosci (2007) 1.15

A Molecular Toolbox for Rapid Generation of Viral Vectors to Up- or Down-Regulate Neuronal Gene Expression in vivo. Front Mol Neurosci (2011) 1.04

Prion pathogenesis is independent of caspase-12. Prion (2007) 1.03

Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J Physiol (2010) 1.02

Articles by these authors

Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med (2013) 4.62

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest (2009) 3.55

Translational regulation of gene expression during conditions of cell stress. Mol Cell (2010) 3.38

Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29

microRNAs in cancer management. Lancet Oncol (2012) 3.24

Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23

Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene (2004) 2.78

The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol (2004) 2.78

BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood (2011) 2.68

The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell (2003) 2.28

The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol Cell (2011) 2.17

Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell (2008) 2.17

Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation (2003) 2.12

Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans (2008) 2.12

The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A (2008) 2.09

Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med (2002) 2.06

Functional genetic analysis reveals a 2-Alkyl-4-quinolone signaling system in the human pathogen Burkholderia pseudomallei and related bacteria. Chem Biol (2006) 2.03

Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J Neurosci (2006) 2.02

TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle (2007) 1.84

Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene (2003) 1.83

p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A (2010) 1.77

Failure of amino acid homeostasis causes cell death following proteasome inhibition. Mol Cell (2012) 1.77

Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell (2006) 1.71

Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A (2008) 1.71

Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr (2005) 1.70

HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species. Nat Immunol (2010) 1.70

microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A (2011) 1.60

How do microRNAs regulate gene expression? Biochem Soc Trans (2008) 1.60

A perspective on mammalian upstream open reading frame function. Int J Biochem Cell Biol (2013) 1.59

The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40 S ribosomal subunits in vitro. J Biol Chem (2003) 1.57

Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev (2009) 1.56

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood (2005) 1.56

A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release. FASEB J (2006) 1.55

Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha. Mol Cell Biol (2002) 1.54

The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol (2011) 1.54

Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry. Genes Dev (2005) 1.53

Experience-dependent strengthening of Drosophila neuromuscular junctions. J Neurosci (2003) 1.52

Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J Biol Chem (2004) 1.51

The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol (2008) 1.48

TAp73 depletion accelerates aging through metabolic dysregulation. Genes Dev (2012) 1.45

Simultaneous quantitative profiling of N-acyl-L-homoserine lactone and 2-alkyl-4(1H)-quinolone families of quorum-sensing signaling molecules using LC-MS/MS. Anal Bioanal Chem (2010) 1.45

A novel method for poly(A) fractionation reveals a large population of mRNAs with a short poly(A) tail in mammalian cells. Nucleic Acids Res (2007) 1.45

Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther (2008) 1.45

Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol (2007) 1.44

An evolutionarily conserved pathway controls proteasome homeostasis. Nature (2016) 1.43

Bag-1 internal ribosome entry segment activity is promoted by structural changes mediated by poly(rC) binding protein 1 and recruitment of polypyrimidine tract binding protein 1. Mol Cell Biol (2004) 1.38

Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Anal Biochem (2006) 1.35

LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process extension in primary cultured neurons. Mol Biol Cell (2004) 1.35

Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast. J Biol Chem (2006) 1.33

p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene (2002) 1.30

Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One (2008) 1.30

Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis Rheum (2010) 1.27

Canonical initiation factor requirements of the Myc family of internal ribosome entry segments. Mol Cell Biol (2009) 1.21

Dysregulation of protein synthesis and disease. J Pathol (2010) 1.21

Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J Cell Sci (2009) 1.20

Polypyrimidine tract binding protein and poly r(C) binding protein 1 interact with the BAG-1 IRES and stimulate its activity in vitro and in vivo. Nucleic Acids Res (2003) 1.19

Comprehensive profiling of N-acylhomoserine lactones produced by Yersinia pseudotuberculosis using liquid chromatography coupled to hybrid quadrupole-linear ion trap mass spectrometry. Anal Bioanal Chem (2006) 1.18

MAP1B regulates axonal development by modulating Rho-GTPase Rac1 activity. Mol Biol Cell (2010) 1.17

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells. Haematologica (2010) 1.17

The involvement of microRNAs in Type 2 diabetes. Biochem Soc Trans (2010) 1.17

The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res (2010) 1.17

High susceptibility of Bt maize to aphids enhances the performance of parasitoids of lepidopteran pests. PLoS One (2007) 1.16

The role of IRES trans-acting factors in regulating translation initiation. Biochem Soc Trans (2010) 1.15

Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J Cell Biol (2011) 1.14

Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology (2008) 1.14

Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol (2005) 1.14

A LuxRI-family regulatory system controls excision and transfer of the Mesorhizobium loti strain R7A symbiosis island by activating expression of two conserved hypothetical genes. Mol Microbiol (2009) 1.13

Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J (2002) 1.13

A diurnal component to the variation in sieve tube amino acid content in wheat. Plant Physiol (2008) 1.13

Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J Mol Biol (2010) 1.13

Intraductal papillary mucinous neoplasm of the biliary tract: a real disease? HPB (Oxford) (2009) 1.10

Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in Mammalian cells. J Biol Chem (2003) 1.10

Host and viral translational mechanisms during cricket paralysis virus infection. J Virol (2009) 1.09

Regulation of membrane expansion at the nerve growth cone. J Cell Sci (2003) 1.08

Regulation of Kv channel expression and neuronal excitability in rat medial nucleus of the trapezoid body maintained in organotypic culture. J Physiol (2010) 1.08

Regulation of Myc by miR-34c: A mechanism to prevent genomic instability? Cell Cycle (2010) 1.08

Targeting the unfolded protein response in neurodegeneration: A new approach to therapy. Neuropharmacology (2013) 1.06

Quantitative measurement of sulforaphane, iberin and their mercapturic acid pathway metabolites in human plasma and urine using liquid chromatography-tandem electrospray ionisation mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.06

Quantitative profiling of nucleotides and related phosphate-containing metabolites in cultured mammalian cells by liquid chromatography tandem electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.06

miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol (2012) 1.04

Comprehensive metabolic profiling of mono- and polyglutamated folates and their precursors in plant and animal tissue using liquid chromatography/negative ion electrospray ionisation tandem mass spectrometry. Rapid Commun Mass Spectrom (2005) 1.04